Through analysis of the PPI network, we obtained 10 potential core targets of C-P therapy for AM: PIK3CA, IL10, IL6, ESR1, CCL2, TP53, VEGFA, FGF2, PTGS2, and CXCL8. This evidence concerns the gene FGF2 and acute myeloblastic leukemia with maturation.